Neuroendocrine Cancer treatment in India by using PRRT Therapy
Theranostics Centre in Delhi NCR offers cutting-edge Peptide Receptor Radionuclide Therapy (PRRT) for patients with Neuroendocrine Tumors (NETs). This advanced, targeted treatment is transforming the way NETs are managed, especially in cases where the disease has spread or is inoperable. As a leading provider of PRRT Therapy in Delhi NCR, we ensure targeted care with precision and improved outcomes for patients battling neuroendocrine tumors.
Resource: https://theranos.care/peptide-....receptor-radionuclid
